Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer
- PMID: 10893286
- DOI: 10.1200/JCO.2000.18.13.2553
Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer
Erratum in
- J Clin Oncol 2000 Nov 15;18(22):3877
Abstract
Purpose: Immediate complete axillary lymphadenectomy (ALND) after sentinel lymphadenectomy (SLND) has confirmed that tumor-negative sentinel nodes accurately predict tumor-free axillary nodes in breast cancer. Therefore, we hypothesized that SLND alone in patients with tumor-negative sentinel nodes would achieve axillary control, with minimal complications.
Patients and methods: Between October 1995 and July 1997, 133 consecutive women who had primary invasive breast tumors clinically </= 4 cm in diameter and no axillary lymphadenopathy were prospectively entered onto a trial of SLND using vital blue dye. Sentinel nodes were examined by standard microscopy or immunohistochemistry. SLND was the only axillary surgery if sentinel nodes were tumor-free. Completion ALND was performed only if sentinel nodes contained metastases or if they were not identified. Excluded from subsequent analysis were patients with unsuspected multifocal carcinoma and those who refused completion ALND. The complication and axillary recurrence rates after SLND without ALND were determined.
Results: Sentinel nodes were identified in 132 (99%) of 133 patients. Eight patients were excluded from further analysis. Of the 125 assessable patients, 57 had tumor-positive sentinel nodes and one had an unsuccessful mapping procedure; these patients underwent completion ALND. In the remaining 67 patients (54%), SLND was the only axillary procedure. Complications occurred in 20 patients (35%) undergoing ALND after SLND but in only two patients (3%) undergoing SLND alone (P =.001). There were no local or axillary recurrences at a median follow-up of 39 months.
Conclusion: Complication rates are negligible after SLND alone. An absence of axillary recurrences supports SLND as an accurate staging alternative for breast cancer and suggests that routine ALND can be eliminated for patients with histopathologically negative sentinel nodes.
Comment in
-
Sentinel nodes: clinical trial data needed.J Clin Oncol. 2000 Nov 15;18(22):3873-4. doi: 10.1200/JCO.2000.18.22.3873. J Clin Oncol. 2000. PMID: 11078501 No abstract available.
-
Safety of sentinel lymph node dissection and significance of cytokeratin micrometastases.J Clin Oncol. 2001 Mar 15;19(6):1882-3. doi: 10.1200/JCO.2001.19.6.1882. J Clin Oncol. 2001. PMID: 11251022 No abstract available.
Similar articles
-
Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg. 1995 Sep;222(3):394-9; discussion 399-401. doi: 10.1097/00000658-199509000-00016. Ann Surg. 1995. PMID: 7677468 Free PMC article. Review.
-
Sentinel lymphadenectomy in breast cancer.J Clin Oncol. 1997 Jun;15(6):2345-50. doi: 10.1200/JCO.1997.15.6.2345. J Clin Oncol. 1997. PMID: 9196149
-
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.Ann Surg. 2016 Sep;264(3):413-20. doi: 10.1097/SLA.0000000000001863. Ann Surg. 2016. PMID: 27513155 Free PMC article. Clinical Trial.
-
When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.Ann Surg Oncol. 2013 Feb;20(2):627-32. doi: 10.1245/s10434-012-2642-6. Epub 2012 Sep 7. Ann Surg Oncol. 2013. PMID: 22956069
-
Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.Dan Med J. 2012 Jul;59(7):B4475. Dan Med J. 2012. PMID: 22759850 Review.
Cited by
-
Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients.Surg Today. 2012 Feb;42(3):245-9. doi: 10.1007/s00595-011-0088-2. Epub 2011 Dec 14. Surg Today. 2012. PMID: 22167482
-
Adverse effects of dyes used in sentinel node biopsy on immunocytochemical determination of hormone receptors in breast cancer cells.J Clin Pathol. 2007 Jun;60(6):730-2. doi: 10.1136/jcp.2006.044974. J Clin Pathol. 2007. PMID: 17557875 Free PMC article. No abstract available.
-
Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients.Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):932-6. doi: 10.1007/s00259-005-1763-6. Epub 2005 Mar 25. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791433 Clinical Trial.
-
Axillary recurrence after negative sentinel node biopsy in a patient with breast cancer: report of a case.Surg Today. 2006;36(3):267-9. doi: 10.1007/s00595-005-3149-6. Surg Today. 2006. PMID: 16493538
-
Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid.Postgrad Med J. 2004 Sep;80(947):546-50. doi: 10.1136/pgmj.2003.016311. Postgrad Med J. 2004. PMID: 15356357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical